Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites

Journal of Neuroscience

Volumn 33, Issue 15, 2013, Pages 6298-6309

  Liot, Geraldine ^a,b,c,d,g   Zala, Diana ^a,b,c   Pla, Patrick ^a,b,c,d   Mottet, Guillaume ^a,e   Piel, Matthieu ^a,f   Saudou, Frederic ^a,b,c  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c INSERM U1005   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSTITUT CURIE   (France)

^f INSTITUT CURIE   (France)

^g Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DYNEIN ADENOSINE TRIPHOSPHATASE; HUNTINGTIN; POLYGLUTAMINE; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; BRAIN CELL; CELL FRACTIONATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITE; EMBRYO; FRACTIONATION; GENE SILENCING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MICROTUBULE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; RETROGRADE NERVE FIBER TRANSPORT; WESTERN BLOTTING;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; CORPUS STRIATUM; DENDRITES; DISEASE MODELS, ANIMAL; DYNEINS; HUNTINGTON DISEASE; MICE; MICROTUBULES; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PRIMARY CELL CULTURE; PROTEIN TRANSPORT; RATS; RECEPTOR, TRKB; SIGNAL TRANSDUCTION; TRANSPORT VESICLES;

EID: 84875509193     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2033-12.2013     Document Type: Article

References (54)

1. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neu-rotrophic factor and its role in the brain. Nature 389:856-860.
2. Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250-4258.
3. Baydyuk M, Russell T, Liao GY, Zang K, An JJ, Reichardt LF, Xu B (2011) TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proc Natl Acad Sci U S A 108:1669-1674.
4. Bhattacharyya A, Watson FL, Pomeroy SL, Zhang YZ, Stiles CD, Segal RA (2002) High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J Neurobiol 51:302-312.
5. Borrell-Pagès M, Zala D, Humbert S, Saudou F (2006a) Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63:2642-2660.
6. Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Néri C, Alberch J, Brouillet E, Saudou F, Humbert S (2006b) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116:1410-1424.
7. Bosse KE, Maina FK, Birbeck JA, France MM, Roberts JJ, Colombo ML, Mathews TA (2012) Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice. J Neurochem 120: 385-395.
8. Braunstein KE, Eschbach J, Ròna-Vörös K, Soylu R, Mikrouli E, Larmet Y, René F, Gonzalez De Aguilar JL, Loeffler JP, Müller HP, Bucher S, Kaulisch T, Niessen HG, Tillmanns J, Fischer K, Schwalenstöcker B, Kas-subek J, Pichler B, Stiller D, Petersen A, et al. (2010) A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet 19:4385-4398.
9. Campenot RB (1977) Local control ofneurite developmentby nerve growth factor. Proc Natl Acad Sci U S A 74:4516-4519.
10. Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, Muñoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neu-rotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24:7727-7739.
11. Caviston JP, Holzbaur EL (2006) Microtubule motors at the intersection of trafficking and transport. Trends Cell Biol 16:530-537.
12. Caviston JP, Holzbaur EL (2009) Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol 19:147-155.
13. Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL (2007) Hunting-tin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A 104:10045-10050.
14. Caviston JP, Zajac AL, Tokito M, Holzbaur EL (2011) Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lyso-somes. Mol Biol Cell 22:478-492.
15. Cohen MS, Bas Orth C, Kim HJ, Jeon NL, Jaffrey SR (2011) Neurotrophin-mediated dendrite-to-nucleus signaling revealed by microfluidic compart-mentalization of dendrites. Proc Natl Acad Sci U S A 108:11246-11251.
16. Colin E, Zala D, Liot G, Rangone H, Borrell-Pagès M, Li XJ, Saudou F, Humbert S (2008) Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J 27:2124-2134.
17. Cosker KE, Courchesne SL, Segal RA (2008) Action in the axon: generation and transport of signaling endosomes. Curr Opin Neurobiol 18:270-275.
18. Cui B, Wu C, Chen L, Ramirez A, Bearer EL, Li WP, Mobley WC, Chu S (2007) One at a time, live tracking of NGF axonal transport using quantum dots. Proc Natl Acad Sci U S A 104:13666-13671.
19. Deinhardt K, Salinas S, Verastegui C, Watson R, Worth D, Hanrahan S, Bucci C, Schiavo G (2006) Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52:293-305.
20. Dompierre JP, Godin JD, Charrin BC, Cordelières FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetyla-tion. J Neurosci 27:3571-3583.
21. Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Déglon N (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65:276-285.
22. Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, Cord-elières FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127-138.
23. Gharami K, Xie Y, An JJ, Tonegawa S, Xu B (2008) Brain-derived neu-rotrophic factor over-expression in the forebrain ameliorates Hunting-ton's disease phenotypes in mice. J Neurochem 105:369-379.
24. Ginés S, Bosch M, Marco S, Gavaldà N, Díaz-Hernández M, Lucas JJ, Canals JM, Alberch J (2006) Reduced expression of the TrkB receptor in Hun-tington's disease mouse models and in human brain. Eur J Neurosci 23:649-658.
25. Ginés S, Paoletti P, Alberch J (2010) Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/ p46 Shc expression. J Biol Chem 285:21537-21548.
26. Ginty DD, Segal RA (2002) Retrograde neurotrophin signaling: Trk-ing along the axon. Curr Opin Neurobiol 12:268-274.
27. Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LS (2003) Disruption of ax-onal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25-40.
28. Ha J, Lo KW, Myers KR, Carr TM, Humsi MK, Rasoul BA, Segal RA, Pfister KK (2008) A neuron-specific cytoplasmic dynein isoform preferentially transports TrkB signaling endosomes. J Cell Biol 181:1027-1039.
29. Heerssen HM, Pazyra MF, Segal RA (2004) Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat Neuro-sci 7:596-604.
30. Her LS, Goldstein LS (2008) Enhanced sensitivity of striatal neurons to ax-onal transport defects induced by mutant huntingtin. J Neurosci 28: 13662-13672.
31. Hirokawa N, Niwa S, Tanaka Y (2010) Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68:610-638.
32. Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32/ ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19:5409-5419.
33. Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc 1:2406-2415.
34. Kapitein LC, Hoogenraad CC (2011) Which way to go? Cytoskeletal organization and polarized transport in neurons. Mol Cell Neurosci 46:9-20.
35. Kapitein LC, Schlager MA, Kuijpers M, Wulf PS, van Spronsen M, MacKintosh FC, Hoogenraad CC (2010) Mixed microtubules steer dynein-driven cargo transport into dendrites. Curr Biol 20:290-299.
36. Keryer G, Pineda JR, Liot G, Kim J, Dietrich P, Benstaali C, Smith K, Cord-elières FP, Spassky N, Ferrante RJ, Dragatsis I, Saudou F (2011) Cilio-genesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest 121:4372-4382.
37. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, Ginty DD (2004) A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell 118:243-255.
38. Mende-Mueller LM, Toneff T, Hwang SR, Chesselet MF, Hook VY (2001) Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci 21:1830-1837.
39. Pal A, Severin F, Lommer B, Shevchenko A, Zerial M (2006) Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol 172:605-618.
40. Pineda JR, Pardo R, Zala D, Yu H, Humbert S, Saudou F (2009) Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain 2:33.
41. Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S, Erne B, Sendtner M, Schaeren-Wiemers N, Korte M, Barde YA (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30: 1739-1749.
42. Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
43. Stepanova T, Slemmer J, Hoogenraad CC, Lansbergen G, Dortland B, De Zeeuw CI, Grosveld F, van Cappellen G, Akhmanova A, Galjart N (2003) Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein). J Neurosci 23:2655-2664.
44. Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, Young M, Faber PW, MacDonald ME, McPhaul MJ, Brady ST (2003) Neuro-pathogenic forms ofhuntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41-52.
45. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2:599-605.
46. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persi-chetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799-2809.
47. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, et al. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195-8209.
48. Valdez G, Akmentin W, Philippidou P, Kuruvilla R, Ginty DD, Halegoua S (2005) Pincher-mediated macroendocytosis underlies retrograde signaling by neurotrophin receptors. J Neurosci 25:5236-5247.
49. Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacha-ryya A, Pomeroy SL, Segal RA (1999) Rapide nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 19:7889-7900.
50. Wheeler VC, Gutekunst CA, Vrbanac V, Lebel LA, Schilling G, Hersch S, Friedlander RM, Gusella JF, Vonsattel JP, Borchelt DR, MacDonald ME (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633-640.
51. Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J Neurosci 30:14708-14718.
52. Yano H, Lee FS, Kong H, Chuang J, Arevalo J, Perez P, Sung C, Chao MV (2001) Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci 21:RC125.
53. Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F (2008) Phos-phorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 17:3837-3846.
54. Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol 18:225-238.